Title |
Reduction of microglial activity in a model of multiple sclerosis by dipyridamole
|
---|---|
Published in |
Journal of Neuroinflammation, July 2013
|
DOI | 10.1186/1742-2094-10-89 |
Pubmed ID | |
Authors |
Scott Sloka, Luanne M Metz, Walter Hader, Yves Starreveld, V Wee Yong |
Abstract |
Despite extensive and persistent activation of microglia in multiple sclerosis (MS), microglia inhibitors have not yet been identified for treatment of the disorder. We sought to identify medications already in clinical use that could inhibit the activation of microglia. On the basis of the reported inhibitory effects of dipyridamole on phosphodiesterase activity that result in the production of various anti-inflammatory outcomes, we selected it for study. Dipyridamole is used clinically for secondary prevention in stroke. In this study, dipyridamole was examined using microglia in culture and in the mouse model of MS, experimental autoimmune encephalomyelitis (EAE). |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 2 | 3% |
Unknown | 56 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 10 | 17% |
Student > Bachelor | 10 | 17% |
Researcher | 8 | 14% |
Student > Master | 7 | 12% |
Student > Postgraduate | 5 | 9% |
Other | 10 | 17% |
Unknown | 8 | 14% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 18 | 31% |
Agricultural and Biological Sciences | 12 | 21% |
Neuroscience | 7 | 12% |
Pharmacology, Toxicology and Pharmaceutical Science | 3 | 5% |
Biochemistry, Genetics and Molecular Biology | 2 | 3% |
Other | 5 | 9% |
Unknown | 11 | 19% |